| Literature DB >> 36230777 |
David Riedl1,2, Thomas Licht3,4, Alain Nickels3,4, Maria Rothmund2,5, Gerhard Rumpold2, Bernhard Holzner6, Vincent Grote1, Michael J Fischer1,7, Gustav Fischmeister3,4.
Abstract
Rehabilitation is a key element in improving health-related quality of life (HRQOL) for pediatric cancer survivors. The aim of this study was to present data from a multidisciplinary inpatient rehabilitation treatment. Children took part in a four-week multidisciplinary family-oriented inpatient rehabilitation. A total of 236 children (>5-21 years) and 478 parents routinely completed electronic patient-reported outcomes (ePROs), performance-based assessments, and clinician-rated assessments before (T1) and at the end (T2) of rehabilitation. HRQOL was assessed with the PedsQL generic core and PedsQL cancer module. Data were analyzed using repeated measures analysis of variance (ANOVA). Statistically significant improvements with medium to large effect sizes were observed for most HRQOL scales (η2 = 0.09-0.31), as well as performance-based and clinician-rated assessments for physical activity and functional status (η2 > 0.28). Agreement between children's PROs and parents' proxy ratings was lower before (rICC = 0.72) than after (rICC = 0.86) rehabilitation. While the concordance between children and parents' assessment of changes during rehab was low to moderate (r = 0.19-0.59), the use of the performance score led to substantially increased scores (r = 0.29-0.68). The results of this naturalistic observational study thus highlight the benefits of multidisciplinary pediatric inpatient rehabilitation for childhood cancer survivors. The use of the performance score is recommended in this field.Entities:
Keywords: HRQOL; observational study; pediatric cancer; pediatric rehabilitation; performance score
Year: 2022 PMID: 36230777 PMCID: PMC9563065 DOI: 10.3390/cancers14194855
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.575
Treatment modalities: overview over therapeutic measures per patient during the rehabilitation.
| Treatment Modality |
| (%) | Treatment Frequency per Patient | |
|---|---|---|---|---|
| Median | IQR | |||
| Guidance and treatment by physician | 236 | (100.0%) | 6 | 5–7 |
| Nursing procedures | 236 | (100.0%) | 4 | 3–8 |
| Speech therapy | 206 | (87.3%) | 2 | 1–4 |
| Nutritional counseling | 236 | (100.0%) | 5 | 4–6 |
| Social counseling | 226 | (95.8%) | 2 | 1.75–2 |
| Physiotherapy | 236 | (100.0%) | 36 | 30–42 |
| Massage | 179 | (75.8%) | 3 | 2–4 |
| Functional occupational therapy | 235 | (99.6%) | 13 | 10–16 |
| Animal assisted therapy | 55 | (23.3%) | 1 | 1–2 |
| Psychological therapy | 236 | (100.0%) | 10.5 | 9–13 |
| Pedagogical interventions | 161 | (68.2%) | 3 | 2–5 |
n: number of patients who received specific treatment at least once (percentage of patients of the whole collective); IQR: interquartile range.
Patient characteristics pediatric oncological rehabilitation (n = 236).
| Mean age (SD) | 11.0 | (4.3) |
| (range) | (5–22) | |
| Sex | ||
| Male | 139 | 58.9% |
| Female | 97 | 41.1% |
| Mean body mass index, BMI (SD) | 20.0 | (5.0) |
| (range) | (12.7–33.1) | |
| Mean initial walking range in meter (SD) | 519.6 | (118.6) |
| (range) | (0–745) | |
| Karnofsky Performance Score | ||
| High level of functioning (80–100%) | 183 | 77.5% |
| Medium level of functioning (50–80%) | 49 | 20.8% |
| Low level of functioning (0–50%) | 2 | 0.8% |
| Missing information | 2 | 0.8% |
| Cancer Entities | ||
| Leukemias (C91–C96) | 83 | 35.2% |
| Malignant lymphoma (C81–C86; C88) | 46 | 19.5% |
| Brain cancers (C70–72) | 32 | 13.6% |
| Bone cancer (C40–C41) | 27 | 11.4% |
| Neoplasms of soft tissue (C47–C49) | 18 | 7.6% |
| Neoplasms of blood and immune system (D50–D89) | 15 | 6.4% |
| Other | 15 | 6.4% |
Self-reported quality of life before and after rehabilitation (child report).
| T1 | T2 | diff | |||||
|---|---|---|---|---|---|---|---|
| Mean | (SD) | Mean | (SD) | (T2-T1) | η2 | ||
| PedsQL generic core scale | |||||||
| Physical functioning | 73.9 | 19.6 | 81.4 | 15.6 | 7.5 | <0.001 | 0.183 |
| Emotional functioning | 76.2 | 20.7 | 81.5 | 18.6 | 5.3 | <0.001 | 0.088 |
| Social functioning | 79.9 | 16.5 | 84.2 | 17.4 | 4.3 | 0.005 | 0.043 |
| School functioning | 71.1 | 18.4 | 76.6 | 19.0 | 5.5 | <0.001 | 0.116 |
| Psychosocial functioning | 75.8 | 14.6 | 80.8 | 15.1 | 5.0 | <0.001 | 0.123 |
| Total score | 75.1 | 14.5 | 81.0 | 13.8 | 5.9 | <0.001 | 0.180 |
| PedsQL Cancer Module | |||||||
| Pain and hurt | 76.9 | 23.3 | 80.2 | 23.2 | 3.3 | 0.033 | 0.025 |
| Nausea | 79.1 | 18.1 | 81.8 | 16.7 | 2.7 | 0.025 | 0.028 |
| Procedural anxiety | 69.4 | 33.3 | 76.1 | 31.5 | 6.7 | 0.035 | 0.025 |
| Treatment anxiety | 86.3 | 20.5 | 87.5 | 20.9 | 1.2 | 0.27 | 0.007 |
| Worry | 77.7 | 24.9 | 79.6 | 21.6 | 1.9 | 0.056 | 0.020 |
| Cognitive problems | 76.4 | 20.8 | 79.0 | 21.3 | 2.6 | 0.035 | 0.024 |
| Perceived physical appearance | 79.6 | 22.4 | 80.2 | 22.0 | 0.6 | 0.88 | <0.01 |
| Communication | 78.6 | 23.7 | 83.2 | 22.3 | 4.6 | 0.010 | 0.037 |
| Total score | 78.0 | 14.2 | 80.9 | 14.8 | 2.9 | 0.004 | 0.045 |
SD—standard deviation, p-value—level of significance, diff—mean difference; η2—effect size (partial eta square); effect size is considered small for η2 > 0.01, medium for η2 > 0.06, and large for η2 > 0.14.
Self-reported quality of life of the pediatric patients before and after rehabilitation (parent report).
| T1 | T2 | diff | |||||
|---|---|---|---|---|---|---|---|
| Mean | (SD) | Mean | (SD) | (T2-T1) | η2 | ||
| PedsQL generic core scale | |||||||
| Physical functioning | 70.7 | 20.5 | 78.0 | 19.4 | 7.3 | <0.001 | 0.215 |
| Emotional functioning | 64.7 | 18.6 | 74.3 | 17.9 | 9.6 | <0.001 | 0.276 |
| Social functioning | 73.3 | 18.7 | 78.6 | 18.9 | 5.3 | <0.001 | 0.124 |
| School functioning | 69.1 | 19.6 | 76.6 | 19.1 | 7.5 | <0.001 | 0.141 |
| Psychosocial functioning | 69.0 | 14.8 | 76.5 | 15.8 | 7.5 | <0.001 | 0.274 |
| Total score | 69.6 | 15.2 | 77.0 | 15.8 | 7.4 | <0.001 | 0.305 |
| PedsQL Cancer Module | |||||||
| Pain and hurt | 72.0 | 24.9 | 78.6 | 22.6 | 6.6 | <0.001 | 0.093 |
| Nausea | 74.3 | 19.5 | 79.0 | 18.4 | 4.7 | <0.001 | 0.084 |
| Procedural anxiety | 57.1 | 36.1 | 68.7 | 35.0 | 11.6 | <0.001 | 0.169 |
| Treatment anxiety | 79.4 | 23.5 | 84.5 | 22.1 | 5.1 | <0.001 | 0.070 |
| Worry | 76.3 | 24.9 | 82.2 | 23.0 | 5.9 | <0.001 | 0.090 |
| Cognitive problems | 65.5 | 22.2 | 68.5 | 22.8 | 3.0 | 0.009 | 0.020 |
| Perceived physical appearance | 77.0 | 24.7 | 81.3 | 22.0 | 4.3 | <0.001 | 0.048 |
| Communication | 57.7 | 28.8 | 57.4 | 31.1 | −0.2 | 0.84 | <0.01 |
| Total score | 69.7 | 14.7 | 74.8 | 15.5 | 5.1 | <0.001 | 0.176 |
SD—standard deviation, p-value—level of significance, diff—mean difference; η2—effect size (partial eta square); effect size is considered small for η2 > 0.01, medium for η2 > 0.06, and large for η2 > 0.14.
Associations of the children’s self-report and parental proxy ratings before rehabilitation (t0), stratified by patient–mother and patient–father dyads.
| Patient | Mother | Father | Patient–Mother Dyad | Patient–Father Dyad | Mother–Father Dyad | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| m | SD | m | SD | m | SD | rICC | 95% CI |
| rICC | 95% CI |
| rICC | 95% CI |
| |
| Functioning scales | |||||||||||||||
| PF | 78.2 | 19.1 | 72.0 | 18.4 | 68.1 | 19.8 | 0.69 | 0.51–0.80 | <0.001 | 0.65 | 0.37–0.79 | <0.001 | 0.76 | 0.64–0.84 | <0.001 |
| EF | 76.7 | 19.7 | 60.8 | 19.9 | 64.6 | 19.7 | 0.58 | 0.08–0.78 | <0.001 | 0.57 | 0.25–74 | <0.001 | 0.86 | 0.79–0.91 | <0.001 |
| SF | 81.7 | 14.2 | 75.1 | 15.8 | 74.5 | 15.1 | 0.53 | 0.28–0.69 | <0.001 | 0.59 | 0.34–0.74 | <0.001 | 0.78 | 0.66–0.85 | <0.001 |
| SchF | 74.9 | 16.5 | 69.3 | 19.2 | 69.8 | 16.9 | 0.65 | 0.47–0.77 | <0.001 | 0.59 | 0.38–0.73 | <0.001 | 0.80 | 0.70–0.87 | <0.001 |
| PsF | 77.8 | 13.4 | 68.4 | 14.7 | 69.6 | 13.4 | 0.64 | 0.24–0.81 | <0.001 | 0.63 | 0.29–0.79 | <0.001 | 0.86 | 0.79–0.91 | <0.001 |
| TotF | 77.9 | 13.1 | 69.6 | 14.3 | 69.1 | 13.9 | 0.66 | 0.31–0.81 | <0.001 | 0.63 | 0.25–0.80 | <0.001 | 0.84 | 0.77–0.90 | <0.001 |
| Symptom scales | |||||||||||||||
| Pain | 80.4 | 21.8 | 69.3 | 24.0 | 71.6 | 25.7 | 0.73 | 0.48–0.85 | <0.001 | 0.66 | 0.46–0.78 | <0.001 | 0.81 | 0.71–0.87 | <0.001 |
| Nausea | 80.1 | 17.5 | 70.0 | 20.1 | 69.8 | 20.3 | 0.61 | 0.31–0.77 | <0.001 | 0.46 | 0.14–66 | <0.001 | 0.82 | 0.71–0.88 | <0.001 |
| Prod Anx | 67.7 | 33.2 | 59.5 | 35.0 | 63.2 | 33.0 | 0.84 | 0.74–0.90 | <0.001 | 0.78 | 0.66–0.85 | <0.001 | 0.82 | 0.74–0.88 | <0.001 |
| Treat Anx | 87.2 | 19.6 | 78.1 | 23.1 | 80.5 | 21.3 | 0.61 | 0.38–0.75 | <0.001 | 0.52 | 0.29–0.68 | <0.001 | 0.77 | 0.66–0.85 | <0.001 |
| Worry | 80.4 | 24.6 | 71.5 | 25.7 | 72.5 | 23.2 | 0.67 | 0.48–0.78 | <0.001 | 0.64 | 0.45–0.76 | <0.001 | 0.79 | 0.69–0.86 | <0.001 |
| Cogn | 79.3 | 19.9 | 65.2 | 22.4 | 63.3 | 20.1 | 0.49 | 0.15–0.68 | <0.001 | 0.40 | 0.03–0.63 | <0.001 | 0.61 | 0.41–0.74 | <0.001 |
| Perc Attr | 85.0 | 18.8 | 70.2 | 25.2 | 72.8 | 22.1 | 0.50 | 0.16–0.69 | <0.001 | 0.57 | 0.26–0.74 | <0.001 | 0.77 | 0.65–0.85 | <0.001 |
| Comm | 77.8 | 24.5 | 53.7 | 28.7 | 52.8 | 29.4 | −0.36 | −0.97–0.08 | 0.98 | –0.17 | −0.59–0.16 | 0.86 | 0.65 | 0.48–0.77 | <0.001 |
| TotSym | 79.5 | 13.4 | 69.6 | 14.3 | 69.1 | 13.9 | 0.52 | 0.15–0.71 | <0.001 | 0.47 | 0.09–0.68 | <0.001 | 0.84 | 0.77–0.90 | <0.001 |
m—mean score; SD—standard deviation; rICC—intraclass-correlation coefficient; CI—confidence interval; PF—physical functioning; EF—emotional functioning; SF—social functioning; SchF—school functioning; PsF—psychosocial functioning; TotF—total functioning score; Prod Anx—procedural anxiety; Treat Anx—treatment anxiety; Cogn—cognitive problems; Perc Attr—perceived physical appearances; comm—communication; TotSym—total symptom score; rICC < 0.5 = poor, 0.5–0.75 = moderate, 0.75–0.9 = good, and >0.9 = excellent reliability (Koo and Li, 2016) [38].
Associations of the children’s self-report and parental proxy ratings after rehabilitation (T1), stratified by patient–mother and patient–father dyads.
| Patient | Mother | Father | Patient–Mother Dyad | Patient–Father Dyad | Mother–Father Dyad | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| m | SD | m | SD | m | SD | rICC | 95% CI |
| rICC | 95% CI |
| rICC | 95% CI |
| |
| Functioning scales | |||||||||||||||
| PF | 83.5 | 14.5 | 80.4 | 16.3 | 78.3 | 18.4 | 0.86 | 0.76–0.91 | <0.001 | 0.78 | 0.58–0.88 | <0.001 | 0.86 | 0.78–0.91 | <0.001 |
| EF | 79.9 | 20.0 | 74.5 | 20.3 | 73.9 | 20.5 | 0.77 | 0.62–0.86 | <0.001 | 0.76 | 0.60–0.86 | <0.001 | 0.88 | 0.81–0.93 | <0.001 |
| SF | 85.3 | 16.4 | 82.9 | 16.9 | 80.5 | 17.6 | 0.84 | 0.73–0.90 | <0.001 | 0.80 | 0.62–0.89 | <0.001 | 0.82 | 0.71–0.89 | <0.001 |
| SchF | 78.3 | 19.5 | 78.4 | 20.5 | 77.1 | 19.8 | 0.85 | 0.75–0.91 | <0.001 | 0.81 | 0.68–0.88 | <0.001 | 0.79 | 0.67–0.87 | <0.001 |
| PsF | 81.0 | 15.1 | 78.6 | 17.1 | 77.3 | 17.1 | 0.87 | 0.78–0.92 | <0.001 | 0.83 | 0.70–0.90 | <0.001 | 0.86 | 0.77–0.91 | <0.001 |
| TotF | 81.9 | 13.9 | 79.2 | 15.8 | 77.7 | 16.2 | 0.88 | 0.80–0.93 | <0.001 | 0.85 | 0.69–0.92 | <0.001 | 0.88 | 0.81–0.93 | <0.001 |
| Symptom scales | |||||||||||||||
| Pain | 80.8 | 24.5 | 75.4 | 25.1 | 74.8 | 24.0 | 0.78 | 0.64–0.87 | <0.001 | 0.87 | 0.77–0.92 | <0.001 | 0.89 | 0.83–0.94 | <0.001 |
| Nausea | 82.5 | 17.9 | 78.1 | 22.3 | 77.1 | 22.1 | 0.65 | 0.40–0.80 | <0.001 | 0.74 | 0.55–0.86 | <0.001 | 0.84 | 0.72–0.90 | <0.001 |
| Prod Anx | 75.4 | 33.3 | 71.0 | 35.5 | 74.2 | 32.2 | 0.88 | 0.81–0.93 | <0.001 | 0.91 | 0.85–0.95 | <0.001 | 0.86 | 0.77–0.91 | <0.001 |
| Treat Anx | 86.9 | 23.1 | 81.1 | 25.9 | 83.6 | 24.8 | 0.75 | 0.59–0.84 | <0.001 | 0.82 | 0.71–0.89 | <0.001 | 0.85 | 0.76–0.91 | <0.001 |
| Worry | 81.0 | 21.8 | 79.0 | 23.9 | 74.1 | 26.0 | 0.81 | 0.68–0.88 | <0.001 | 0.77 | 0.62–0.87 | <0.001 | 0.79 | 0.68–0.87 | <0.001 |
| Cogn | 80.7 | 20.5 | 68.4 | 23.9 | 65.1 | 22.3 | 0.64 | 0.32–0.80 | <0.001 | 0.40 | 0.01–0.64 | 0.004 | 0.50 | 0.21–0.69 | <0.001 |
| Perc Attr | 84.0 | 20.2 | 80.2 | 23.8 | 75.8 | 25.4 | 0.74 | 0.58–0.84 | <0.001 | 0.64 | 0.41–0.79 | <0.001 | 0.82 | 0.72–0.89 | <0.001 |
| Comm | 81.2 | 25.3 | 54.1 | 32.3 | 46.6 | 30.2 | −0.36 | −10.1–0.13 | 0.96 | 0.01 | −0.27–0.27 | 0.47 | 0.46 | 0.15–0.66 | 0.005 |
| TotSym | 81.4 | 16.0 | 79.2 | 15.8 | 78.8 | 15.1 | 0.79 | 0.65–0.87 | <0.001 | 0.82 | 0.69–0.89 | <0.001 | 0.88 | 0.81–0.93 | <0.001 |
m—mean score; SD—standard deviation; rICC—intraclass-correlation coefficient; CI—confidence interval; PF—physical functioning; EF—emotional functioning; SF—social functioning; SchF—school functioning; PsF—psychosocial functioning; TotF—total functioning score; Prod Anx—procedural anxiety; Treat Anx—treatment anxiety; Cogn—cognitive problems; Perc Attr—perceived physical appearances; comm—communication; TotSym—total symptom score; rICC < 0.5 = poor, 0.5–0.75 = moderate, 0.75–0.9 = good, and >0.9 = excellent reliability (Koo and Li, 2016) [38].
Figure 1Percentage of patients with clinically relevant improvement based on the PedsQL total score presented for each cancer entity for patient self-report and proxy reports.
Comparison of agreement in mean improvement during therapy between children and parents using the delta and the performance score.
| Delta ( | Performance Score ( | |||
|---|---|---|---|---|
| r | r | |||
| PedsQL generic core scale | ||||
| Physical functioning | 0.51 | <0.001 | 0.59 | <0.001 |
| Emotional functioning | 0.36 | <0.001 | 0.52 | <0.001 |
| Social functioning | 0.37 | <0.001 | 0.51 | <0.001 |
| School functioning | 0.45 | <0.001 | 0.60 | <0.001 |
| Psychosocial functioning | 0.53 | <0.001 | 0.65 | <0.001 |
| Total score | 0.59 | <0.001 | 0.68 | <0.001 |
| PedsQL Cancer Module | ||||
| Pain and hurt | 0.28 | 0.004 | 0.42 | <0.001 |
| Nausea | 0.19 | 0.10 | 0.40 | <0.001 |
| Procedural anxiety | 0.20 | 0.043 | 0.60 | <0.001 |
| Treatment anxiety | 0.24 | 0.016 | 0.50 | <0.001 |
| Worry | 0.09 | 0.37 | 0.33 | 0.001 |
| Cognitive problems | 0.26 | 0.009 | 0.29 | 0.003 |
| Perceived physical appearance | 0.43 | <0.001 | 0.49 | <0.001 |
| Communication | <0.01 | 0.99 | −0.09 | 0.35 |
| Total score | 0.45 | <0.001 | 0.60 | <0.001 |
| Mean r-scores | 0.34 | 0.50 | ||
r—Pearson correlation coefficient; delta—mean difference during rehabilitation (T2-T1); performance score—adjusted delta (T2 + (T2-T1)); PF—physical functioning; EF—emotional functioning; SF—social functioning; SchF—school functioning; PsF—psychosocial functioning; TotF—total functioning score; Prod Anx—procedural anxiety; Treat Anx—treatment anxiety; Cogn—cognitive problems; Perc Attr—perceived physical appearances; Comm—communication; TotSym—total symptom score; r < 0.3 = negligible, r = 0.3–0.5 low, 0.5–0.7 moderate, 0.7–0.9 high, and >0.9 excellent correlation (Hinkle, Wiersma, and Jurs, 2003) [40].